Lenvatinib With Pembrolizumab in Patients With Advanced Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
J. Clin. Oncol 2020 Mar 13;[EPub Ahead of Print], V Makker, MH Taylor, C Aghajanian, A Oaknin, J Mier, AL Cohn, M Romeo, R Bratos, MS Brose, C DiSimone, M Messing, DE Stepan, CE Dutcus, J Wu, EV Schmidt, R Orlowski, P Sachdev, R Shumaker, A Casado HerraezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.